Sign in
Optimizing immunomodulatory therapy for MS patients: an integrated management model
Journal article   Peer reviewed

Optimizing immunomodulatory therapy for MS patients: an integrated management model

Douglas Jeffery, Khurram Bashir, Linda Buchwald, Patricia Coyle, Mark Freedman, Clyde Markowitz, Kottil Rammohan, Tony Reder, Mo Sharief and Jerry Wolinsky
Journal of the neurological sciences, Vol.201(1-2), pp.89-90
2002-09-15
PMID: 12163200

Abstract

Interferon-beta - administration & dosage Adjuvants, Immunologic - administration & dosage Drug Therapy - standards Interferon beta-1a Humans Glatiramer Acetate Peptides - administration & dosage Multiple Sclerosis - drug therapy

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.203 Neuromuscular Disorders
1.203.147 Multiple Sclerosis
Web Of Science research areas
Clinical Neurology
Neurosciences
ESI research areas
Neuroscience & Behavior

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details